Billy Evans, partner of Theranos founder Elizabeth Holmes, is launching a new blood-testing venture called Haemanthus, raising eyebrows and questions about repeating past mistakes in health technology.
Billy Evans, partner of Theranos founder Elizabeth Holmes, unveils Haemanthus, a startup aiming to revolutionize health optimization through advanced blood testing. With ambitions to raise over $50 million, this venture echoes Theranos' controversial legacy. Is it a groundbreaking innovation or a repeat of past mistakes?
US court upholds convictions of Theranos' founder Elizabeth Holmes and President Ramesh “Sunny” Balwani for defrauding investors in the failed blood testing startup once valued at $9 billion.
